- Half Year 2024 Healius Ltd Earnings Call TranscriptFeb 27, 2024A$1.27 (-8.66%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptNov 28, 2023
- Healius Ltd Conference Call TranscriptNov 22, 2023
- Full Year 2023 Healius Ltd Earnings Call TranscriptAug 30, 2023A$2.7 (+7.75%)Earnings
- Australian Clinical Labs Ltd To Merge with Healius Ltd Call TranscriptMar 19, 2023
- Half Year 2023 Healius Ltd Earnings Call TranscriptFeb 27, 2023A$2.6 (-4.10%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptOct 20, 2022
- Full Year 2022 Healius Ltd Earnings Call TranscriptAug 30, 2022A$3.54 (+3.51%)Earnings
- Half Year 2022 Healius Ltd Earnings Call TranscriptFeb 23, 2022A$4.08 (+5.25%)Earnings
- Healius Ltd to Acquire Agilex Biolabs Pty Ltd Call TranscriptDec 17, 2021
- Full Year 2021 Healius Ltd Earnings Call TranscriptAug 30, 2021A$4.32 (-7.34%)Earnings
- Half Year 2021 Healius Ltd Earnings Call TranscriptFeb 24, 2021A$3.69 (+2.31%)Earnings
- Healius Ltd Sustainable Improvements Program and Capital Management Plans Call TranscriptDec 08, 2020
- Healius Ltd Annual Shareholders Meeting TranscriptOct 22, 2020
- Full Year 2020 Healius Ltd Earnings Call TranscriptAug 21, 2020A$3.04 (+0.31%)Earnings
- Healius Ltd Sales of Medical Centres and Market Update Presentation TranscriptJun 15, 2020
- Half Year 2020 Healius Ltd Earnings Call TranscriptFeb 26, 2020A$2.94 (+15.22%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptNov 24, 2019
- Full Year 2019 Healius Ltd Earnings Call TranscriptAug 16, 2019A$2.71 (+5.02%)Earnings
Half Year 2022 Healius Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the Healius 2022 Half Year Results Presentation. (Operator Instructions)
I would now like to hand the conference over to Janet Payne. Please go ahead.
Good morning, ladies and gentlemen. And yes, welcome to Healius and to the first half of our financial year 2022 results presentation. Malcolm Parmenter, our CEO and MD; and Maxine Jacquet, our CFO and COO, will take you through our presentation, and then we'll open up for questions. So without further ado, Malcolm, over to you.
Thanks, Janet. Good morning, ladies and gentlemen, and welcome to our results presentation. I'm very pleased to announce our first half '22 financials, which are a beat on consensus. Now obviously, the large number of COVID PCR tests we undertook in the period was a prime driver of our growth. And this would not have been possible without the ongoing selfless
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)